Blog

Gene therapy success in age-related macular degeneration trial – BioNews

Gene therapy success in age-related macular degeneration trial
BioNews
A small, preliminary clinical trial has demonstrated safe and well-tolerated gene therapy to treat wet age-related macular degeneration (AMD). This condition is a leading cause of progressive blindness in adults, and is caused by the abnormal growth

2017-05-22 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.